Golden has been acquired by ComplyAdvantage.Read about it here ⟶

PhaseRx

PhaseRx is a company developing macromolecular therapeutics to treat diseases.

Overview Structured Data Issues Contributors Activity

phaserx.com

Is a

Company

Organization

Company attributes

Industry

RNA-based and RNA-targeted therapeutics

Location

AngelList URL

Pitchbook URL

pitchbook.com/profiles.../52915-15

CIK Number

1,429,3860

Place of Incorporation

Delaware

Investors

Versant Ventures

Brian Atwood

ARCH Venture Partners

5AM Ventures

DUNS Number

8263625060

IRS Number

204,690,6200

Total Funding Amount (USD)

19,000,000

Latest Funding Round Date

February 28, 2008

Latest Funding Type

Series A

NAICS Code

325,4120

CAGE Code

61JD90

Wellfound ID

phaserx

Other attributes

SIC Code

2,8340

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like PhaseRx

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API